Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit?
Krüger
Thilo
T
Division of Nephrology and Clinical Immunology, RWTH University of Aachen, Germany.
Floege
Jürgen
J
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002114:Calcinosis / Q000517:prevention & control; D003374:Coumarins / Q000009:adverse effects*; D006801:Humans; D051379:Mice; D019057:Quality-Adjusted Life Years; D006435:Renal Dialysis / Q000009:adverse effects*; D014812:Vitamin K / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D014812:Vitamin K; C030123:coumarin